Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05220982 · ClinicalTrials.gov registry record · NA

Improving Efficacy of Voice Therapy Concepts Via Telepractice and Mobile App Technology

A NA study of Voice Disorders, sponsored by West Chester University of Pennsylvania.

Recruiting
Registry status
NA
Development phase
32
Enrollment target
1
Study location

NCT05220982 is a NA study of Voice Disorders that is actively recruiting participants, run by West Chester University of Pennsylvania. The registered enrollment target is 32 participants, below the 92-participant average among 7 other Voice Disorders trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05220982, a NA study of Voice Disorders, is actively recruiting participants, sponsored by West Chester University of Pennsylvania.

RECRUITING
Registry status
NA
Development phase
32 participants
Enrollment target
1
Study location

Study Summary

Due to the COVID-19 pandemic, telepractice has grown rapidly. To date, synchronous telepractice (i.e., in real-time videoconferencing) has been the focus of most research with asynchronous telepractice (i.e. information stored and accessed later) being used minimally only to record synchronous encounters. Descriptions of voice therapy concepts are minimally available in the literature with no standard reporting framework and no clinical efficacy or effectiveness data. Thus, the proposed study will address these barriers. First, an asynchronous method will be developed that will impact both in-person and telepractice services by offering repeated learning opportunities in the client's environment. The method includes ecological momentary intervention (EMI) through a daily voice therapy practice app, server, and web portal that is flexible in its programming to meet the needs of the client, offers performance feedback, and charts results over time. Second, voice therapy concepts will be tested improving our knowledge about such concepts that facilitate successful client-centered outcomes for both prevention and treatment of voice problems. The participants in the study will be teachers who have a high prevalence of voice problems, impact the healthcare system when treatment is needed, and negatively affect students' learning abilities in the classroom when communicating with a voice problem. Third, the Rehabilitation Treatment Specification System (RTSS) framework will be used to describe the voice therapy concepts. The concepts include: training multiple voices to meet all the clients' vocal needs, defining voice qualities by the anatomy and physiology of the voice production system, generalizing voice targets into hierarchical speech tasks, and using "new" vs "other/old" voice to help the client become their own clinician. Vocally healthy student teachers and professional teachers with voice complaints will be randomized into one of four voice therapy conditions del

Conditions Studied

Interventions

  • BEHAVIORAL Conversation Training Therapy
  • BEHAVIORAL Global Voice Prevention and Therapy Model
  • BEHAVIORAL Modified Conversation Training Therapy
  • BEHAVIORAL Modified Global Voice Prevention and Therapy Model

Study Locations (1)

Pennsylvania

  • Elizabeth Grillo - West Chester

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2022-08-31
Est. Completion 2025-08-31
Phase NA

What the Registry Record Tells You About NCT05220982

The ClinicalTrials.gov registry entry for NCT05220982 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 92-participant average among 7 other Voice Disorders trials with a reported enrollment target (65% lower). The listed sponsor is West Chester University of Pennsylvania, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Voice Disorders appearing as the primary indexed condition, and to 4 interventions - of which Conversation Training Therapy is the first listed.

NCT05220982 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05220982 about?

NCT05220982 is a clinical study titled "Improving Efficacy of Voice Therapy Concepts Via Telepractice and Mobile App Technology". Due to the COVID-19 pandemic, telepractice has grown rapidly. To date, synchronous telepractice (i.e., in real-time videoconferencing) has been the focus of most research with asynchronous telepractice (i.e. information stored and accessed later) being used minimally only to record synchronous encou...

What is the current status of trial NCT05220982?

This trial is currently recruiting. It is a NA study. The enrollment target is 32 participants. The study started on 2022-08-31. Estimated completion is 2025-08-31.

What conditions does trial NCT05220982 study?

This clinical trial studies the following conditions: Voice Disorders.

What interventions are being tested in trial NCT05220982?

The interventions under investigation include: Conversation Training Therapy (BEHAVIORAL), Global Voice Prevention and Therapy Model (BEHAVIORAL), Modified Conversation Training Therapy (BEHAVIORAL), Modified Global Voice Prevention and Therapy Model (BEHAVIORAL).

Who is sponsoring clinical trial NCT05220982?

This trial is sponsored by West Chester University of Pennsylvania, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05220982 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Voice Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.